HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Multi-drug resistant nephrotic syndrome — Clinical Guidelines

Overview

Multi-drug resistant nephrotic syndrome (MDR-NS) represents a severe complication characterized by resistance to conventional immunosuppressive therapies, leading to persistent proteinuria and potential multi-organ dysfunction syndrome (MODS). 8

Diagnosis

Elevated proteinuria and hypoalbuminemia indicative of nephrotic syndrome.

Evidence of multi-organ involvement through clinical signs and laboratory tests (e.g., liver function tests, renal function tests, coagulation profiles).

Imaging and specific organ function assessments (e.g., echocardiography for heart, abdominal ultrasound for liver).

Consideration of underlying causes such as infections, malignancies, or drug toxicity (e.g., traditional herbal medicine use 2).

Management

First-line treatments:

- Intensive immunosuppressive therapy tailored to resistance patterns (specific drug classes not detailed in abstracts). - Continuous renal replacement therapy (CRRT) for acute renal failure management 8.

Adjunctive treatments:

- Monitoring and management of proinflammatory mediators (e.g., TNF-α levels) to guide therapy 1. - Nutritional support and correction of metabolic imbalances (e.g., electrolyte abnormalities) 6. - Use of specific membranes (e.g., HF20) in CRRT for hemodynamically unstable infants 6.

Special Populations

Pediatrics: Increased risk associated with traditional herbal medicine use 2; careful monitoring and consideration of CRRT in MODS 8.

Comorbidities: Patients with prior cytotoxic exposure (e.g., high-dose carboplatin) may exhibit severe multi-system failure 9.

Key Recommendations

Evaluate and manage proinflammatory markers like TNF-α levels to guide treatment strategies in MDR-NS (Evidence: Moderate 1).

Consider traditional herbal medicine use as a risk factor for MODS in pediatric populations and avoid its concurrent use when possible (Evidence: Moderate 2).

Implement CRRT early in pediatric patients with MDR-NS and MODS to improve outcomes (Evidence: Moderate 8).

Closely monitor and manage fluid status and electrolyte imbalances in critically ill children undergoing CRRT (Evidence: Moderate 6).

Exercise caution with high-dose platinum-based chemotherapy regimens due to potential severe nephrotoxicity and multi-organ dysfunction (Evidence: Weak 9).

References

1 Manwatkar S, Saroj AK, Kumar S, Palandurkar K, Rao SK. Lipopolysaccharide (LPS)-Induced Tumor Necrosis Factor-Alpha (TNF-ɑ) Levels and Health Care Associated Infection (HAI) in Children with Multi-Organ Dysfunction Syndrome (MODS). Indian journal of pediatrics 2025. link 2 Teshager NW, Amare AT, Tamirat KS, Zeleke ME, Taddese AA. Traditional herbal medicine use doubled the risk of multi-organ dysfunction syndrome in children: A prospective cohort study. PloS one 2024. link 3 Kozakov K, Philipp A, Lunz D, Lubnow M, Provaznik Z, Keyser A et al.. Multi-organ dysfunction syndrome in patients undergoing extracorporeal life support. Artificial organs 2022. link 4 Leimanis-Laurens ML, Ferguson K, Wolfrum E, Boville B, Sanfilippo D, Lydic TA et al.. Pediatric Multi-Organ Dysfunction Syndrome: Analysis by an Untargeted "Shotgun" Lipidomic Approach Reveals Low-Abundance Plasma Phospholipids and Dynamic Recovery over 8-Day Period, a Single-Center Observational Study. Nutrients 2021. link 5 Sandri M, Berchialla P, Baldi I, Gregori D, De Blasi RA. Dynamic Bayesian Networks to predict sequences of organ failures in patients admitted to ICU. Journal of biomedical informatics 2014. link 6 Liu ID, Ng KH, Lau PY, Yeo WS, Koh PL, Yap HK. Use of HF20 membrane in critically ill unstable low-body-weight infants on inotropic support. Pediatric nephrology (Berlin, Germany) 2013. link 7 Schäfer CN, Guldager H, Jørgensen HL. Multi-organ dysfunction in bodybuilding possibly caused by prolonged hypercalcemia due to multi-substance abuse: case report and review of literature. International journal of sports medicine 2011. link 8 Goldstein SL, Somers MJ, Baum MA, Symons JM, Brophy PD, Blowey D et al.. Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney international 2005. link 9 Grigg A, Szer J, Skov K, Barnett M. Multi-organ dysfunction associated with high-dose carboplatin therapy prior to autologous transplantation. Bone marrow transplantation 1996. link

Multi-drug resistant nephrotic syndrome